DCUN1D5 and breast carcinoma: Notably, 5-year relapse-free survival rate was also decreased in breast cancer patients with high DCUN1D5 expression retrieved from Kaplan–Maier Plotter (https://kmplot.com/analysis/; accessed on 3 March 2021) [51] (Figure 6F).